arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

CVRx, Inc.

CVRX
$2.38 ▼ -3.55 (-59.90%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
26 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
16
Health
Poor
Bearish
auto_awesome

Analytical Summary

CVRx, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $62.7M
Dividend Yield
Revenue Growth 19.6%
Op. Margin -82.3%
ROIC -13.9%
FCF / Share $-0.47
Trailing P/E
Price / Book 2.2x
FCF Yield
Debt / Equity 2.01
info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$14.77M
↑ +19.6%
Net Income Profit after all expenses
$-13.12M
↑ +4.7%
Operating Margin Operating profit as % of sales
-82.3%
↓ -18.0% 3th
FCF / Share Free cash flow per share
$-0.47
↑ +6.4%
Long-Term Debt Long-term obligations
$58.49M
↑ +18.1%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
3
Returns
6
Financial Health
26
Cash Quality
52

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters